Pavilion Compounding Pharmacy
FDA inspection history across 2 sites, 2019 to 2020
- 2
- Responses
- 1
- Untitled letter
- 1
- Form 483
Every document, by year
- Response
- Untitled letter
- Form 483
2019: one 483 response and one Form 483; 2020: one untitled letter response and one untitled letter.
The story so far
Built from the dates and citations on the documents themselves.
- 2019–20One 483 response, one Form 483, one untitled letter response and one untitled letter, at Atlanta, Georgia and Georgia.
Cited most
Across all Pavilion Compounding Pharmacy observations on file
- FDCA 501(a)(2)(A)Insanitary conditions2
- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.165(a)Testing and release for distribution1
- 21 CFR 211.188Batch production and control records1
The complete Pavilion Compounding Pharmacy file.
All 4 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Georgia
One untitled letter response and one untitled letter · 2020
Latest: Response, Dec 9, 2020 →Atlanta, Georgia
One 483 response and one Form 483 · 2019 · 5 observations
Latest: Response, Feb 27, 2019 →
Documents
4 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2020-12-09 | Response Untitled letter response | Georgia | — | $199 |
| 2020-11-06 | Untitled letter Untitled letter | Georgia | — | $99 |
| 2019-02-27 | Response 483 response | Atlanta, Georgia | — | $199 |
| 2019-02-08 | 483 Form 483 | Atlanta, Georgia | 5 | $99 |
Investigators on these documents
FEI number 3004570352 · most recent document Dec 9, 2020
About Pavilion Compounding Pharmacy
How many FDA Form 483s has Pavilion Compounding Pharmacy received?
FDA Intel has 1 Form 483 on file for Pavilion Compounding Pharmacy; the most recent is dated Feb 8, 2019.
When was Pavilion Compounding Pharmacy last inspected by FDA?
The most recent FDA inspection document on file for Pavilion Compounding Pharmacy is a Form 483 dated Feb 8, 2019, for the site in Atlanta, Georgia.
What did FDA cite at Pavilion Compounding Pharmacy?
The regulations cited most in the observations on file for Pavilion Compounding Pharmacy are FDCA 501(a)(2)(A) (Insanitary conditions), 2 times; 21 CFR 211.113 (Control of microbiological contamination), 1 time; 21 CFR 211.165(a) (Testing and release for distribution), 1 time.
Has Pavilion Compounding Pharmacy received an FDA untitled letter?
Yes. FDA Intel has 1 FDA untitled letter on file for Pavilion Compounding Pharmacy; the most recent is dated Nov 6, 2020. An untitled letter is FDA's enforcement letter for violations that don't rise to warning-letter level.